GMO (Jeremy Grantham) — ALB Trade History

Quarter-by-quarter changes in the ALBEMARLE CORP position · CUSIP 012653101
Currently held · 2.5 YearsFirst seen: 2018 Q1
QuarterFiledActivitySharesΔ SharesΔ %Value% Port.
2026 Q22026-08-13Reduce897,013-9,670-1.1%$121.1M0.27%
2026 Q12026-05-14Reduce906,683-16,388-1.8%$162.8M0.42%
2025 Q42026-02-17Add923,071191,582+26.2%$130.6M0.33%
2025 Q32025-11-13Reduce731,489-104,317-12.5%$59.3M0.17%
2025 Q22025-08-13Add835,80647,200+6.0%$52.4M0.16%
2025 Q12025-05-14Add788,606175,608+28.6%$56.8M0.18%
2024 Q42025-02-13Add612,99897,000+18.8%$52.8M0.17%
2024 Q32024-11-13Add515,998433,798+527.7%$48.9M0.15%
2024 Q22024-08-13Add82,2005,800+7.6%$7.9M0.03%
2024 Q12024-05-14New76,40076,400$10.1M0.04%
2023 Q42024-02-13
2023 Q32023-11-13
2023 Q22023-08-14
2023 Q12023-05-12Sold out-6,262-100.0%
2022 Q42023-02-13Add6,2623,000+92.0%$1.4M0.01%
2022 Q32022-11-10New3,2623,262$863.0K0.01%
2022 Q22022-08-12
2022 Q12022-05-13
2021 Q42022-02-11
2021 Q32021-11-12
2021 Q22021-08-12Sold out-128,195-100.0%
2021 Q12021-05-13Add128,19583,273+185.4%$18.7M0.10%
2020 Q42021-02-12Reduce44,922-12,109-21.2%$6.6M0.04%
2020 Q32020-11-13Reduce57,031-74,070-56.5%$5.1M0.04%
2020 Q22020-08-13Reduce131,101-137,809-51.2%$10.1M0.07%
2020 Q12020-05-14Reduce268,910-167,790-38.4%$15.2M0.13%
2019 Q42020-02-13Add436,70043,600+11.1%$31.9M0.21%
2019 Q32019-11-13Reduce393,100-56,500-12.6%$27.3M0.19%
2019 Q22019-08-13Add449,600249,000+124.1%$31.7M0.22%
2019 Q12019-05-14Add200,6006,200+3.2%$16.4M0.12%
2018 Q42019-02-13Add194,40031,300+19.2%$15.0M0.12%
2018 Q32018-11-14Add163,10028,700+21.4%$16.3M0.11%
2018 Q22018-08-14Add134,40058,000+75.9%$12.7M0.09%
2018 Q12018-05-15New76,40076,400$7.1M0.04%
2017 Q42018-02-14
2017 Q32017-11-14
2017 Q22017-08-14
2017 Q12017-05-15
2016 Q42017-02-13
2016 Q32016-11-10

Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.